A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

Clinical trial NCT07389239 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07389239
Sponsor: University of Chicago
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Advanced Malignant Solid Tumor

Start date: 2026-06-23
Primary completion: 2031-12-10
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.